Atrys Health, S.A. (BME:ATRY)

Atrys Health Revenue

Atrys Health had revenue of 78.62M EUR in the half year ending June 30, 2026, a decrease of -31.33%. This brings the company's total for the last twelve months to 151.86M. In the year 2025, Atrys Health had annual revenue of 146.37M with 3.35% growth. That makes Atrys Health the 18,891st largest company in the world by revenue and 99th in Spain.

• Revenue (ttm): 151.86M
• Revenue Growth: +3.35%
• P/S Ratio: 1.37
• Revenue / Employee: 193.55K
• Employees: 763
• Market Cap: 201.15M

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Medicine Precision - Oncology 75.48M 52.3%
• Medicine Precision - Diagnosis 68.84M 47.7%

By Geography

Chart

• Spain 80.63M 57.2%
• Latin America 44.22M 31.4%
• Portugal 16.16M 11.5%

Fiscal year ended Dec 31, 2025 See the full Atrys Health breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	146.37M	4.74M	3.35%
Dec 31, 2024	141.63M	-65.37M	-31.58%
Dec 31, 2023	207.00M	42.86M	26.11%
Dec 31, 2022	164.14M	36.30M	28.39%
Dec 31, 2021	127.84M	93.12M	268.23%
Dec 31, 2020	34.72M	17.74M	104.45%
Dec 31, 2019	16.98M	7.36M	76.57%
Dec 31, 2018	9.62M	1.29M	15.44%
Dec 31, 2017	8.33M	2.00M	31.54%
Dec 31, 2016	6.33M	1.72M	37.35%
Dec 31, 2015	4.61M	-	-

Data Sources: Fiscal.ai and S&P Global Market Intelligence Last updated: Sep 10, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every six months for this company. Revenue segment and geography data is provided by S&P Global Market Intelligence.

Update frequency:

Semi-annually

Last checked:

Oct 25, 2026

Data Sources Report a data error